Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats.
about
Microbial translocation in chronic liver diseasesProbiotics for patients with hepatic encephalopathyIntestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trialsThe gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cellsGut Microbiota and Lifestyle Interventions in NAFLDDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetGut Microbiota and Hepatocellular CarcinomaRelevant Aspects of Nutritional and Dietary Interventions in Non-Alcoholic Fatty Liver DiseaseModulation of the gut microbiota by nutrients with prebiotic and probiotic propertiesDietary habits and behaviors associated with nonalcoholic fatty liver diseaseTherapeutic options in pediatric non alcoholic fatty liver disease: current status and future directionsBifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.Pediatric non-alcoholic fatty liver disease: New insights and future directionsPathogenesis of non-alcoholic fatty liver disease.Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver diseaseEffects of four Bifidobacteria on obesity in high-fat diet induced rats.Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters.Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategiesEffects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.Gut microbiome and metabolic diseases.Anti-obesity effects of gut microbiota are associated with lactic acid bacteria.Microbiota and nonalcoholic steatohepatitis.Gut microbiota and diabetes: from pathogenesis to therapeutic perspective.Secreted Metabolites of Bifidobacterium infantis and Lactobacillus acidophilus Protect Immature Human Enterocytes from IL-1β-Induced Inflammation: A Transcription Profiling Analysis.Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice.Rutin Increases Muscle Mitochondrial Biogenesis with AMPK Activation in High-Fat Diet-Induced Obese RatsPrecision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.Probiotics Blunt the Anti-Hypertensive Effect of Blueberry Feeding in Hypertensive Rats without Altering Hippuric Acid ProductionProtective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed RatsGreen tea powder and Lactobacillus plantarum affect gut microbiota, lipid metabolism and inflammation in high-fat fed C57BL/6J mice.Probiotics and their Effects on Metabolic Diseases: An Update.The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical TrialThe Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Microbiota and gut-liver axis: their influences on obesity and obesity-related liver diseaseGreen tea extract protects against nonalcoholic steatohepatitis in ob/ob mice by decreasing oxidative and nitrative stress responses induced by proinflammatory enzymes.Probiotics as a novel treatment for non-alcoholic Fatty liver disease; a systematic review on the current evidencesRole of gut microbiota in liver diseases.
P2860
Q21284997-703098A0-BD31-4D1E-987D-E61FEA354671Q24235259-D9D1508B-F353-4488-8F48-3031A50B09F4Q24600527-0B89E41F-9E0B-4CD4-BD6B-F3A71C86D442Q24633800-6AA2B7FD-448A-43D7-B03A-DC53EB3916F0Q26749783-5EE885A9-2821-4711-9604-18798A5A7CF7Q26752614-14D8BDBC-B389-43D8-BDB2-BDAA901BC02AQ26775568-9958E005-1E68-4BFC-B93A-352F1E13A2E4Q26778020-B3E58C79-2C78-4AFD-B2A8-99AEFE9A471AQ26823918-2365EBF5-FA00-4677-AD58-B7906AA6A71DQ26830594-0E521CFC-D984-4D1B-B82F-DAEEAF1FB9B2Q27028844-42C228AD-5931-43F9-AB50-6F2D2A8C243DQ28546415-52CCF69D-B31B-4411-ABF3-245E2FF2C667Q30412771-F113858B-F407-44BB-A598-1C77AC8CEBD0Q33563887-9E17B48F-51CC-460F-9574-A6D8F0BC9625Q33606303-E8C0D3C2-65C3-4006-B390-B52291E478F4Q33650508-AAA823D4-1AC4-4B88-A735-661BE827DE11Q33780172-83D7AB38-ACB1-42AC-994D-73BAC3A4FA23Q33998629-817FE4F5-B7A4-44BD-A18F-9DFE43B63E93Q34499017-D4F1728B-B666-4B1A-A355-AFAF882316B6Q34648009-10D38CBD-3092-478F-BD68-C7BA56F101F4Q34657286-5A15DBB2-84CF-40D8-B6B6-27C2BCEA4D17Q34827887-46B89B31-1C41-4D09-BDFA-2917A9B89040Q35033105-AC3528CF-EFA6-43B4-A9B8-9F1DB635A0E1Q35043138-C68CD27E-83F2-4149-B7DE-7861BC8B115DQ35066721-A0B25CE5-7055-4A74-A059-CEDCA79E7F22Q35573510-A499D185-3452-4AB5-BC49-33D1C0064B23Q35612905-CCBDF6B4-95C5-4872-9781-FE4E1A59D734Q35679003-31AB29F3-5B13-43B0-95C2-39BAF88A0329Q36102201-4DCFBC43-6622-4D4E-A6D4-6DE33CCAC616Q36148926-8722A1B1-F29F-45D2-8901-C4713E76FF1FQ36257682-13D5F5CF-3020-423D-AFF9-9FE151B55301Q36401269-6BBCFA8D-5CA2-4D0B-BFAE-052C539AB335Q36513460-6D03AF5A-8B2F-4E89-8799-99DE9ED0443AQ36622603-F78C6107-4FB5-4F7C-A194-5565C018E336Q36732958-4096E2DF-865C-4F9C-9533-E275E1093F73Q36751990-C49A421B-8F73-4108-A047-D46F604C6098Q36798196-4E786835-D6CE-4DB5-A637-3E7D9D2A3D81Q36991482-9014172C-0754-4BB3-BA1E-FD13A9D0313BQ37034650-CB30D430-7B30-487C-B6EA-2D8866F57658Q37488165-58648221-9051-445E-B810-E452C6741A30
P2860
Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Probiotics reduce the inflamma ...... et in the liver of young rats.
@ast
Probiotics reduce the inflamma ...... et in the liver of young rats.
@en
Probiotics reduce the inflamma ...... et in the liver of young rats.
@nl
type
label
Probiotics reduce the inflamma ...... et in the liver of young rats.
@ast
Probiotics reduce the inflamma ...... et in the liver of young rats.
@en
Probiotics reduce the inflamma ...... et in the liver of young rats.
@nl
prefLabel
Probiotics reduce the inflamma ...... et in the liver of young rats.
@ast
Probiotics reduce the inflamma ...... et in the liver of young rats.
@en
Probiotics reduce the inflamma ...... et in the liver of young rats.
@nl
P2093
P50
P356
P1433
P1476
Probiotics reduce the inflamma ...... et in the liver of young rats.
@en
P2093
Anna Iacono
Emanuela Esposito
Giuseppe Bianco
Giuseppina Autore
Giuseppina Mattace Raso
P304
P356
10.3945/JN.108.101808
P407
P577
2009-03-25T00:00:00Z